Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Sotalol in hyperthyroidism

S Kaur, G Krassas, I Ramsay

Clinical Endocrinology

|December 1, 1981

Summary

This summary is machine-generated.

Sotalol, a beta-adrenoceptor blocker, significantly reduced pulse and blood pressure in hyperthyroid patients. However, it did not resolve metabolic issues, indicating it's unsuitable as a sole hyperthyroidism treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Offset integrity reduces environmental risk: Using lessons from biodiversity and carbon offsetting to inform water quality offsetting in the catchments of the Great Barrier Reef.

The Science of the total environment·2024

Same author

Cross-sectional study of the prevalence, causes and management of hospital-onset diarrhoea.

The Journal of hospital infection·2019

Same author

Randomised prospective single-blinded study comparing 'inside-out' versus 'outside-in' transobturator tapes in the management of urodynamic stress incontinence: 1-year outcomes from the E-TOT study.

BJOG : an international journal of obstetrics and gynaecology·2010

Same author

Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association.

Journal of endocrinological investigation·2010

Same author

Effect of abdominal hysterectomy on developing urinary and faecal incontinence later in life.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2009

Same author

Urogynaecology: a review.

Scottish medical journal·2009

Area of Science:

Endocrinology
Cardiovascular Pharmacology

Background:

Hyperthyroidism presents with elevated thyroid hormones, impacting cardiovascular and metabolic functions.
Beta-adrenoceptor blockade is a common therapeutic approach for managing hyperthyroid symptoms.

Purpose of the Study:

To evaluate the effects of sotalol, a beta-adrenoceptor blocker, on various physiological and metabolic parameters in patients with hyperthyroidism.
To determine the efficacy of sotalol as a standalone treatment for hyperthyroidism.

Main Methods:

A cohort of ten hyperthyroid patients underwent assessment before and after a two-week treatment with sotalol.
Measurements included heart rate, blood pressure, body weight, thyroid hormones, plasma lipids, liver function tests, glucose metabolism, and urinary excretion of specific compounds.

Related Experiment Videos

Main Results:

Sotalol administration resulted in a statistically significant reduction in resting pulse rate and blood pressure.
Patients continued to experience weight loss during the sotalol treatment period.
No significant or consequential metabolic alterations were observed.

Conclusions:

While sotalol effectively manages the cardiovascular symptoms of hyperthyroidism, it does not address underlying metabolic derangements.
Sotalol should not be considered as the exclusive treatment modality for patients diagnosed with hyperthyroidism.